Vortex speeds cancer drug discovery

One of the world’s foremost cancer research establishments, The Institute of Cancer Research in London, has deployed Dotmatics’ data visualisation and analysis tool Vortex to help discover and develop new cancer drugs.

Vortex is designed specifically for analysis and interrogation of scientific data, providing users with an out-of-the-box filtering, charting, plotting, and chemically aware calculations engine. Scientists can evaluate large datasets in a rich, intuitive and flexible user interface. The use of Vortex helps uncover hidden data trends and correlations and identify potential drug candidates.

After rigorous internal testing, The Institute of Cancer Research (ICR) selected Vortex because of its ‘flexibility, ease of use and swift integration with our existing chemoinformatics data storage platform', said Professor Julian Blagg, head of chemistry and deputy director of the division of cancer therapeutics at The Institute of Cancer Research. ‘It allows the visualisation of multidimensional datasets on compounds of interest to study trends, relationships and to discover outliers,’ he added.

Dotmatics, based in Bishops Stortford south of Cambridge, UK, is a scientific software company deploying web-based knowledge solutions that improve the way scientific data is queried, managed and shared within companies. Dotmatics has significant expertise in cheminformatics and bioinformatics techniques including chemical databases, SAR analysis, data management and data visualisation.

Twitter icon
Google icon icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon

Gemma Church finds out how astronomers are using simulations to investigate the extremities of our universe


Turning data into scientific insight is not a straightforward matter, writes Sophia Ktori


The Leibniz Supercomputing Centre (LRZ) is driving the development of new energy-efficient practices for HPC, as Robert Roe discovers


William Payne investigates the growing trend of using modular HPC, built on industry standard hardware and software, to support users across a range of both existing and emerging application areas


Robert Roe looks at developments in crash testing simulation – including larger, more intricate simulations, the use of optimisation software, and the development of new methodologies through collaboration between ISVs, commercial companies, and research organisations